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Cytoskeleton preparations derived from lactoperoxidase-radioiodinated human erythrocytes were found to 
be enriched in a labelled component with the same apparent molecular mass as the Rhesus (D) (Rh(D)) 
antigen polypeptide. Immune precipitation from the cytoskeleton preparations confirmed that this compo- 
nent is the Rh(D) polypeptide. The results suggest hat the Rh(D) polypeptide may be linked to the erythro- 
cyte skeletal matrix. The possibility that the Rh(D) antigen is involved in maintaining the shape and viability 
of the erythrocyte is discussed. 
Antigen Cytoskeleton Erythrocyte 
1. INTRODUCTION 
Recent studies have identified the polypeptide 
carrying the human erythrocyte Rh(D) antigen as a 
28.532-kDa component. This polypeptide can be 
labelled by lactoperoxidase-catalysed radioiodina- 
tion of intact erythrocytes, and can be specifically 
immune precipitated by human anti-Rh(D) serum 
[ 1,2]. Further studies have shown that this integral 
membrane polypeptide is apparently not 
glycosylated [3]. The functional role of the Rh(D) 
polypeptide is unknown. Here, we suggest that this 
component may- be a site of linkage of the 
erythrocyte cytoskeletal complex with the 
membrane. 
2. MATERIALS AND METHODS 
Lactoperoxidase-catalysed radioiodination of 
intact erythrocytes using Na12? (Amersham Inter- 
national; spec. act. 13.4 Ci/Fg) and the prepara- 
tion of membranes from radiolabelled erythrocytes 
by lysis in 5 mM sodium phosphate (pH 8.0) were 
carried out as in [ 11. Cytoskeletons were prepared 
by Triton X-100 extraction of membranes from 
radiolabelled erythrocytes as in [4]. The results in 
fig. 1 were obtained from cytoskeletons extracted 
with 1% Triton X-100 in 5 mM sodium phosphate 
(pH 8.0) containing 1 mM EDTA (pH 8.0), 1 mM 
dithiothreitol and 0.2 mM phenylmethylsulphonyl 
fluoride. Where specified 10 mM Tris-Cl (pH 7.0) 
or 150 mM NaCl was substituted for sodium 
phosphate in the extraction buffer. 
Human anti-D serum was kindly provided by Dr Phospholipids were extracted as in [ 131 and lipid 
S. Moore (South East Regional Blood Transfusion phosphate determined as in [14]. Immunopre- 
Service, The Royal Infirmary, Edinburgh, cipitation of radiolabelled components from 
Scotland). -D- erythrocytes were provided by Mrs Triton X-lOO-solubilized erythrocyte ghosts was 
M. Leak, South London Blood Transfusion Cen- performed as in [l]. Immunoprecipitation of 
tre, Tooting, London, and cDE control radiolabelled components from cytoskeletons 
erythrocytes drawn at a similar time were available prepared from 1 ml membranes was performed 
from the South West Regional Blood Transfusion similarly except that the initial binding of the an- 
Membrane protein Rhesus polypeptide 
Service, Bristol. Rh,n erythrocytes (donor S.S.) 
were kindly provided by P.D. Issitt, South Florida 
Blood Service, Miami, USA. 
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tibody was to the cytoskeleton preparation rather 
than to intact erythrocytes. 
SDS-polyacrylamide gel electrophoresis of 
samples was carried out as in [5]. After elec- 
trophoresis, gels were fixed in methanol/acetic 
acid/water (5: 1:5, by vol.) for 30 min at 55°C 
dried and exposed to Kodak XAR-5 film. 
3. RESULTS AND DISCUSSION 
The red cell cytoskeleton is operationally de- 
fined as the residues remaining after non-ionic 
detergent extraction of human erythrocyte ghosts 
[6]. Cytoskeletons prepared from membranes 
derived from radioiodinated intact human 
erythrocytes of phenotype cDE and -D- were 
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the same molecular mass as the Rh(D) polypeptide 
(fig.1). This band contained much more radioac- 
tivity in the membranes and cytoskeletons from 
D- cells than from cDE cells in accord with the 
significantly greater abundance of Rh(D) antigen 
sites in -D- cells over cDE cells (see below). Similar 
experiments with Rh,,rr erythrocytes (which lack 
all the antigens of the Rhesus blood group system) 
did not show the presence of this band in the 
cytoskeletons (not shown). The identification of 
this labelled component as the Rh(D) polypeptide 
was confirmed by immunoprecipitation from the 
cytoskeletal preparation using human anti-Rh(D) 
serum (fig. 1). The labelled band was im- 
munoprecipitated from cytoskeletons from both 
cDE and -D- erythrocytes and had the same ap- 
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Fig. 1. Labelling of intact erythrocytes with lz51, preparation of cytoskeletons from ‘2sI-labelled rythrocyte membranes, 
and immunoprecipitation of labelled membrane components. (a-d) Autoradiographs of: (a) solubilized membranes 
from 12sI-labelled cDE erythrocytes; (b) cytoskeletons prepared from 12’I-labelled cDE erythrocytes; (c) solubilized 
membranes from ‘251-labelled -D- erythrocytes; (d) cytoskeletons prepared from 1251-labelled -D- erythrocytes. Exposure 
period: (a,b) 5 weeks; (c,d) 2 weeks. (e-i) Autoradiographs of (e) solubilized membranes from ‘251-labelled cDE 
erythrocytes; (f) components from ‘251-labelled control erythrocytes precipitated by human anti-Rh(D) serum; (g) 
solubilized membranes from ‘251-labelled -D- erythrocytes; (h) components from ‘251-labelled -D- erythrocytes 
precipitated by human anti-Rh(D) serum; (i) components from cytoskeletons prepared from 1251-labelled -D- 
erythrocytes precipitated by human anti-Rh(D) serum. 
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tact cDE and -D- erythrocyte membranes by anti- 
Rh(D) serum (fig. 1). 
The results shown in fig.1 were derived from 
cytoskeletons prepared using extraction of 
erythrocyte membranes with 1% Triton X-100 in 
5 mM sodium phosphate (pH 8.0). The Rh(D) 
polypeptide was retained in the cytoskeletal 
preparation even when the Triton X-100 concen- 
tration was raised to 5% but was not apparent in 
cytoskeletons prepared using 10% Triton X-100 
(not shown). It was important to show that the 
Rh(D) polypeptide was not present in the 
cytoskeletal preparations simply because of 
hydrophobic association with residual lipid rather 
than with the cytoskeletal proteins. Since 
phospholipid analysis could not be satisfactorily 
carried out on cytoskeletons prepared using extrac- 
tion in phosphate buffers, similar experiments 
were carried out with cytoskeletons prepared with 
10 mM Tris-Cl (pH 7.0) or 150 mM NaCl. Results 
were obtained which were similar to those in fig.1 
and showed that the Rh(D) polypeptide was retain- 
ed in cytoskeletons prepared using either 10 mM 
Tris-Cl or 150 mM NaCl at 1 and 5% Triton 
X-100, but was not apparent when the Triton 
X-100 concentration was raised to 10%. The 
results of phospholipid analysis of these 
cytoskeleton preparations are shown in table 1. 
Removal of up to 90% of the ghost phospholipid 
did not affect the retention of the Rh(D) polypep- 
tide in the cytoskeletons. These results are similar 
to those found for the well characterized associa- 
tion of that proportion of erythrocyte band 3 
which is associated with the cytoskeleton [l 11. 
The above results suggest that he Rh(D) 
polypeptide may be linked to the human 
erythrocyte cytoskeleton. This transmembrane 
Table 1 
Phospholipid content of cytoskeleton preparations 
Triton X-100 % ghost phospholipid retained 
(%) 
150 mM NaCl 10 mM Tris-Cl 
1 32 + 12 (3) 20 * 5 (3) 
5 14 + 5 (2) 9 f 3 (3) 
10 6.5 + 1 (2) 5 I!I 2 (3) 
Results are means + SD, with the number of 
determinations in parentheses 
polypeptide could form an attachment site for the 
skeletal matrix with the membrane. This would be 
additional to the well characterised interaction bet- 
ween ankyrin and band 3 [7] and the possible in- 
teraction between the cytoskeleton and glycocon- 
nectin [4,12]. Estimates of the number of Rh(D) 
antigen sites in cDE and -D- cells have yielded 
values of approx. 40000 and 150000 sites per cell, 
respectively [8]. Thus, the pqtential number of 
membrane attachment sites in -D- cells provided by 
the Rh(D) polypeptide would be similar in 
magnitude to the number of band 3 molecules 
bound to ankyrin [7]. 
The erythrocyte cytoskeleton is believed to play 
an important role in maintaining the shape and in- 
tegrity of the red cell membrane. There are known 
associations between altered erythrocyte shape and 
the Rh blood group system. Rh,u erythrocytes 
have a total lack of all antigens within the Rhesus 
blood group system and have an abnormal shape 
(stomatocytosis). The condition is associated with 
mild chronic haemolytic anaemia and the cells 
have an increased osmotic fragility [9]. These cells 
appear to lack two extracellular sulphydryl-group- 
containing polypeptides, one of which is identical 
to the Rh(D) polypeptide [5]. There is also a 
genetic linkage between the Rh blood group system 
and certain forms of elliptocytosis [lo]. 
These observations together with the present 
results suggest that the Rh(D) polypeptide may 
play an important functional role in the 
maintenance of cell shape and viability in the 
erythrocyte. 
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